{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:03:28Z","timestamp":1761217408961,"version":"3.44.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.clp.2010.08.002","type":"journal-article","created":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T04:16:53Z","timestamp":1289708213000},"page":"873-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Clinical Care of the HIV-1\u2013Infected Infant"],"prefix":"10.1016","volume":"37","author":[{"given":"Andres F.","family":"Camacho-Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison C.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.clp.2010.08.002_bib1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"author":"UNAIDS\/WHO","key":"10.1016\/j.clp.2010.08.002_bib3"},{"issue":"21","key":"10.1016\/j.clp.2010.08.002_bib4","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1001\/jama.288.21.2679","article-title":"From the Centers for Disease Control and Prevention. HIV testing among pregnant women\u2013United States and Canada, 1998\u20132001","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clp.2010.08.002_bib5","first-page":"97","article-title":"Racial\/ethnic disparities among children with diagnoses of perinatal HIV infection\u201334 states, 2004\u20132007","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.clp.2010.08.002_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199811123392001","article-title":"Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus","volume":"339","author":"Wade","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"RR-14","key":"10.1016\/j.clp.2010.08.002_bib7","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"48","key":"10.1016\/j.clp.2010.08.002_bib8","first-page":"721","article-title":"Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III\/lymphadenopathy-associated virus and acquired immunodeficiency syndrome","volume":"34","author":"Centers for Disease Control (CDC)","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5 Pt 1","key":"10.1016\/j.clp.2010.08.002_bib9","first-page":"977","article-title":"Human milk, breastfeeding, and transmission of human immunodeficiency virus in the United States. American Academy of Pediatrics Committee on Pediatric AIDS","volume":"96","year":"1995","journal-title":"Pediatrics"},{"author":"Perinatal HIV Guidelines Working Group","key":"10.1016\/j.clp.2010.08.002_bib10"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1542\/peds.112.5.1196","article-title":"Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics Committee on pediatric AIDS","volume":"112","author":"Read","year":"2003","journal-title":"Pediatrics"},{"issue":"8434","key":"10.1016\/j.clp.2010.08.002_bib12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(85)91673-3","article-title":"Postnatal transmission of AIDS-associated retrovirus from mother to infant","volume":"1","author":"Ziegler","year":"1985","journal-title":"Lancet"},{"issue":"RR-19","key":"10.1016\/j.clp.2010.08.002_bib13","first-page":"63","article-title":"Revised recommendations for HIV screening of pregnant women","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Recomm Rep"},{"author":"Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children","key":"10.1016\/j.clp.2010.08.002_bib14"},{"issue":"12","key":"10.1016\/j.clp.2010.08.002_bib15","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.4049\/jimmunol.174.12.8191","article-title":"Correlates of delayed disease progression in HIV-1-infected Kenyan children","volume":"174","author":"Chakraborty","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJM199402033300502","article-title":"Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery","volume":"330","author":"Blanche","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.clp.2010.08.002_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3476(95)70110-9","article-title":"Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1","volume":"127","author":"Just","year":"1995","journal-title":"J\u00a0Pediatr"},{"issue":"19","key":"10.1016\/j.clp.2010.08.002_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM199611073351904","article-title":"Early progression of disease in HIV-infected infants with thymus dysfunction","volume":"335","author":"Kourtis","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/315678","article-title":"Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods","volume":"182","author":"Kuhn","year":"2000","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/314551","article-title":"Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study","volume":"179","author":"Kuhn","year":"1999","journal-title":"J\u00a0Infect Dis"},{"issue":"19","key":"10.1016\/j.clp.2010.08.002_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM199705083361901","article-title":"Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group","volume":"336","author":"Shearer","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.clp.2010.08.002_bib22","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/09540120120063241","article-title":"Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs","volume":"13","author":"Steele","year":"2001","journal-title":"AIDS Care"},{"issue":"3","key":"10.1016\/j.clp.2010.08.002_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pec.2005.05.006","article-title":"HIV treatment-related knowledge and self-efficacy among caregivers of HIV-infected children","volume":"61","author":"Nicholson","year":"2006","journal-title":"Patient Educ Couns"},{"issue":"8","key":"10.1016\/j.clp.2010.08.002_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/00006454-199908000-00006","article-title":"Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1","volume":"18","author":"Watson","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006454-200301000-00015","article-title":"Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial","volume":"22","author":"Gibb","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.clp.2010.08.002_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/dkl557","article-title":"HLA-B*5701 screening for susceptibility to abacavir hypersensitivity","volume":"59","author":"Lucas","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9308","key":"10.1016\/j.clp.2010.08.002_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clp.2010.08.002_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/sti.77.3.158","article-title":"Mitochondrial toxicity and HIV therapy","volume":"77","author":"White","year":"2001","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.clp.2010.08.002_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","article-title":"Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity","volume":"22","author":"Kakuda","year":"2000","journal-title":"Clin Ther"},{"issue":"14","key":"10.1016\/j.clp.2010.08.002_bib31","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.aids.0000216367.23325.58","article-title":"Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis","volume":"20","author":"Lewis","year":"2006","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib33","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1542\/peds.2004-0955","article-title":"Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals","volume":"114","author":"Noguera","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.clp.2010.08.002_bib34","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1542\/peds.2006-0371","article-title":"Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hepatites Virales 1209 Study, Abidjan, Ivory Coast","volume":"118","author":"Ekouevi","year":"2006","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.clp.2010.08.002_bib35","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/00002030-200307040-00020","article-title":"Lactate levels in children with HIV\/AIDS on highly active antiretroviral therapy","volume":"17","author":"Desai","year":"2003","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.clp.2010.08.002_bib36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/01.inf.0000083826.11124.b1","article-title":"Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment","volume":"22","author":"Noguera","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.clp.2010.08.002_bib37","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00002030-200308150-00006","article-title":"Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort","volume":"17","author":"Barret","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/313921","article-title":"Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors","volume":"31","author":"Brinkman","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.clp.2010.08.002_bib39","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/339041","article-title":"Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature","volume":"34","author":"Falco","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.clp.2010.08.002_bib40","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1097\/00002030-200311210-00012","article-title":"Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis","volume":"17","author":"Lonergan","year":"2003","journal-title":"AIDS"},{"issue":"9396","key":"10.1016\/j.clp.2010.08.002_bib41","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(03)14793-9","article-title":"Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis","volume":"362","author":"Dunn","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clp.2010.08.002_bib42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.aids.0000232237.20792.68","article-title":"Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children","volume":"20","author":"HIV Paediatric Prognostic Markers Collaborative Study","year":"2006","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.clp.2010.08.002_bib43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/524686","article-title":"Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults","volume":"197","author":"Dunn","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2010.08.002_bib44","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1542\/peds.109.4.e61","article-title":"Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection","volume":"109","author":"Van Dyke","year":"2002","journal-title":"Pediatrics"},{"issue":"7551","key":"10.1016\/j.clp.2010.08.002_bib45","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.332.7551.1183","article-title":"Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997\u20132005: cohort study","volume":"332","author":"Menson","year":"2006","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.clp.2010.08.002_bib46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.qai.0000225871.87456.e7","article-title":"Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York state","volume":"42","author":"Karchava","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.clp.2010.08.002_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00126334-200303010-00008","article-title":"Prevalence of genotypic drug resistance among a cohort of HIV-infected newborns","volume":"32","author":"Parker","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"11","key":"10.1016\/j.clp.2010.08.002_bib49","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1469-0691.2004.00974.x","article-title":"High seroprevalence of pneumocystis infection in Spanish children","volume":"10","author":"Respaldiza","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.clp.2010.08.002_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijid.2005.06.007","article-title":"Clinical indicators of Pneumocystis jiroveci pneumonia (PCP) in South African children infected with the human immunodeficiency virus","volume":"10","author":"Fatti","year":"2006","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.clp.2010.08.002_bib51","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1086\/343049","article-title":"Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia","volume":"35","author":"Madhi","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"RR-11","key":"10.1016\/j.clp.2010.08.002_bib52","first-page":"1","volume":"58","author":"Mofenson","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.clp.2010.08.002_bib53","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00006454-200012000-00004","article-title":"Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children","volume":"19","author":"Madhi","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/520651","article-title":"Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy","volume":"45","author":"Aurpibul","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"29","key":"10.1016\/j.clp.2010.08.002_bib55","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1016\/j.vaccine.2007.05.006","article-title":"Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy","volume":"25","author":"Lao-araya","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib56","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.inf.0000160942.84169.14","article-title":"Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children","volume":"24","author":"Madhi","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"16","key":"10.1016\/j.clp.2010.08.002_bib57","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.vaccine.2006.01.045","article-title":"Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy","volume":"24","author":"Siriaksorn","year":"2006","journal-title":"Vaccine"},{"issue":"RR-16","key":"10.1016\/j.clp.2010.08.002_bib58","first-page":"1","article-title":"A\u00a0comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2010.08.002_bib59","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1086\/605027","article-title":"A\u00a0review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children","volume":"200","author":"Steele","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.clp.2010.08.002_bib60","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1542\/peds.2009-0466","article-title":"Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine","volume":"123","author":"Committee on Infectious Diseases","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib61","first-page":"61","article-title":"Immunization of children at risk of infection with human immunodeficiency virus","volume":"81","author":"Moss","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.clp.2010.08.002_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00002030-199902250-00014","article-title":"Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group","volume":"13","author":"Mock","year":"1999","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2010.08.002_bib64","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/00002030-200304001-00016","article-title":"Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy","volume":"17","author":"Miller","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib65","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1542\/peds.111.1.e52","article-title":"Height, weight, and growth in children born to mothers with HIV-1 infection in Europe","volume":"111","author":"Newell","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1179\/146532808X270699","article-title":"Growth parameters in HIV-vertically-infected adolescents on antiretroviral therapy in Rio de Janeiro, Brazil","volume":"28","author":"Buonora","year":"2008","journal-title":"Ann Trop Paediatr"},{"issue":"3","key":"10.1016\/j.clp.2010.08.002_bib67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1651-2227.2004.tb02964.x","article-title":"Human immunodeficiency virus infection, diarrheal disease and sociodemographic predictors of child growth","volume":"93","author":"Villamor","year":"2004","journal-title":"Acta Paediatr"},{"issue":"12","key":"10.1016\/j.clp.2010.08.002_bib68","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/apc.2009.0093","article-title":"Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"23","author":"Aurpibul","year":"2009","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"10.1016\/j.clp.2010.08.002_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2006.10.006","article-title":"Neurologic and neurodevelopmental manifestations of pediatric HIV\/AIDS: a global perspective","volume":"11","author":"Van Rie","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"10.1016\/j.clp.2010.08.002_bib70","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1371\/journal.pmed.0020247","article-title":"The stigma of being HIV-positive in Africa","volume":"2","author":"Rankin","year":"2005","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.clp.2010.08.002_bib71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/QAI.0b013e3181b323ff","article-title":"Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus Study","volume":"52","author":"Kilewo","year":"2009","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"Suppl 4","key":"10.1016\/j.clp.2010.08.002_bib72","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/01.aids.0000279708.09180.f5","article-title":"Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV","volume":"21","author":"Palombi","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.002_bib73","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana","volume":"362","author":"Shapiro","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2010.08.002_bib74","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa0911486","article-title":"Maternal or infant antiretroviral drugs to reduce HIV-1 transmission","volume":"362","author":"Chasela","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510810000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510810000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:55:29Z","timestamp":1758815729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510810000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0095510810000953"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2010.08.002","relation":{},"ISSN":["0095-5108"],"issn-type":[{"type":"print","value":"0095-5108"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Care of the HIV-1\u2013Infected Infant","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2010.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}